AmCham Slovakia

Download conference brochure (.PDF)

READ THE OFFICIAL PRESS RELEASE

The COVID-19 pandemic has accelerated systemic changes that were apparent before its inception. Most urgent systemic changes are about to happen in the field of healthcare & innovation. The pandemic has raised the importance of healthcare sector and of its institutions and stakeholders accelerating and extending their innovation efforts. The healthcare sector holds a massive jolt of urgency to embrace new tools and technologies.

The AmCham conference is a pioneering the interconnection and cooperation of slovak leaders in health care and technology sector to shape the principles, policies and partnerships needed in this challenging new context. It is essential for leaders from these areas to work together for a more inclusive, cohesive and sustainable future as soon as possible in 2021.

MAIN TOPICS

1. GLOBAL TRENDS IN CUTTING-EDGE RESEARCH & INVESTMENTS FOR HEALTH CARE

• Investing in health research
• Bioconvergence - future of medicine

2. ACCELERATING ACCESS TO INOVATION FOR SLOVAK PATIENT 

• Investments in “Economic” Value of Innovative Treatments
• Value-Based Healthcare
• Telemedicine
• Innovative Diagnostics (Biobank)
• AI in Healthcare

3. OPEN & INTEROPERABLE DATA FOR BETTER HEALTH CARE 

• Health Cybersecurity

Agenda (download .PDF)

AGENDA

09:00 OPENING REMARKS

Welcome speech: Health Innovation to meet slovak patients needs

• Gabriel Galgóci, AmCham President, AT&T Country Manager 
  
• Vladimír Mičieta, Country Manager, Medtronic

Talk with: 

• Róbert Babela, State Secretary of the Ministry of Health of the Slovak Republic
• Zuzana Kovačič-Hanzelová (Moderator)

How will Covid-19 transform health systems in the post-pandemic era? Defining research and innovation investments priorities and opportunities

• Federico Pratellesi, DG Sante, European Commission
  
• Ľudmila Majláthová, Representation of the European Commission in Slovakia 

9.45  ACCELERATING ACCESS TO INOVATION FOR SLOVAK PATIENT

Innovative treatments – Investments in “Economic” Value of Innovative Treatments and Medical Technology 

• Chat with Jasper Kunow, Managing Director for Central Eastern Europe, MSD 

Panel discussion:

• Róbert Babela, State Secretary of the Ministry of Health of the Slovak Republic
• Boris Masloviec, Government Office of the Slovak Republic
  
• Alica Sukupová, Director of Health Policy, VsZP
• Marián Streško, Head of the Oncology Clinic at the University Hospital in Trnava
• Jasper Kunow, Managing Director for Central Eastern Europe, MSD
  
• Zuzana Kovačič-Hanzelová (Moderator)

10.45  Coffee break

11.00  Innovative Diagnostics of patients tissue and blood samples as essential prerequisite for innovative treatments

• Ales Ryška, President of the European Society of Pathology 

Panel Discussion:

• Lukáš Plank, Head of the Department of Pathology of the Comenius University Jessenius Medical Faculty and University Hospital in Martin 
  
• Michal Konečný, President of the Slovak Society of Medical Genetics 
• Beata Havelková, Vice-Chairwoman of the Board of Directors of VšZP
  
• Zuzana Kovačič-Hanzelová (Moderator)
  

12.00  Telehealth: The role of telemedicine during and post Covid-19 outbreak

• Ľubica Kováčiková, The National Institute for Cardiovascular Diseases

Current Barriers to Telehealth in Slovakia

• Vladimír Mičieta, Country Manager, Medtronic
  

Panel Discussion: 

• Robert Hatala, Head of the Depart. of Cardiology and Angiology, Faculty of Medicine, SZU
• Vladimír Mičieta, Country Manager, Medtronic
• Marian Faktor, Director of Relations with Healthcare Providers, Dovera
• Lukas Palaj, Director, Ministry of Health of the Slovak Republic
• Matej Adam, Digital health expert (MoH CZ, VZP CZ, NCZI SK)
• Zuzana Kovačič-Hanzelová (Moderator)

13.00  LUNCH BREAK

13.45  Bioconvergence - Future of Medicine/ Israel success story 

• Karina Rubinstein, Israel Innovation Authority representative (online)

We live in a post-genomic era, where data, molecular engineering, and new frameworks redefine possibilities. Researchers, engineers, and biotech firms are moving beyond the “nature-inspired” paradigm. The lines between biology, engineering, nanotech, and IT are becoming increasingly blurred. What we’re seeing here isn’t just gradual iteration. It’s a revolution, a mass convergence of multiple different fields: Bioconvergence.

Israel continues to shine as hub of med-tech innovation. In recent years, Israel has proven to be a hot spot for med-tech innovation. The country boasts more than 1,500 companies in the health care and life sciences sectors, roughly 70% in medical devices and digital health. More than a hundred new companies focused on medical technology launch each year.

14.00  Patient Journey: Innovative solutions/Cutting-edge technologies

• Ruthy Kaidar, Director Health Industry Sector Central & Eastern Europe Microsoft
• Tobias Heimann, Siemens Healthineers: AI & Softwer Solutions for Diagnostics

Panel discussion:

• Miriam Lapuníková, Director, FNsP BB
  
• Ľuboš Iro, Siemens Healthineers
• Štefan Korec, Clinical Oncologist, President Onkoaliancia
• Dmitry Etin, Solution Architect for Healthcare, Oracle
• Zuzana Kovačič-Hanzelová (Moderator)

• Veronika Hudzíková, Deutsche Telekom IT Solutions Slovakia
• Richard Bodnar, Deutsche Telekom IT Solutions Slovakia
  

• Viktor Svetský, Ministry of Health of the Slovak Republic
  
• Zuzana Šimeková, Founder and CEO of INLY
• Marek Madro, Founder and Program Dirctor, IPcko
• Marcela Havrilová, Education Industry Lead at Microsoft CZ/SK
• Tomáš Jucha, General Director, MIRRI (Moderator)

• Fridrich Matejík, Country Leader, IBM
• Peter Kišac, IT Administrator, F.D. Roosevelt General Hospital of Banská Bystrica (FDRH)
  
• Dalibor Kacmar, National Technology Officer, Microsoft  
• Zuzana Kovačič-Hanzelová (Moderator)

16.50  Value Based Public Procurement  

• Bogdan Fratiloiu, Compliance Value Lead Romania, Data Protection Officer, Roche Romania SRL

Panel Discussion:

• Jaroslav Lexa, Vice Chair, The Office for Public Procurement
  
• Ondrej Kuruc, Director, Ministry of Health of the Slovak Republic 
• Martin Smatana, Healthcare analyst at MSquare, a.s & Health Fellow at Globsec 
• Pavol Lepey, Head of Healthcare Transformation & Market Access, Roche Slovensko
• Zuzana Kovačič-Hanzelová (Moderator)

BECOME A PARTNER

Be the one to share your latest developments applied to healthcare and become our partner.

See the sponsorship opportunities and contact us at petra.zappe@amcham.sk

IMPORTANT: Due to the latest pandemic restrictions, entry exclusively for guests who are vaccinated.